Silver Book Fact

Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.

MEDTAP International, Inc. The Value of Investment in Health Care: Better care, better lives. Bethesda, MD: MEDTAP; 2004. http://www.aha.org/content/00-10/08affordability-value.pdf

Reference

Title
The Value of Investment in Health Care: Better care, better lives
Publisher
MEDTAP
Publication Date
2004
Authors
MEDTAP International, Inc
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • Every additional dollar spent on the overall treatment of stroke has produced health gains valued at $1.55.  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  
  • Without antihypertensive drug therapy, there would have been about 572,000 more hospital discharges for stroke in 2002 and 261,000 more discharges for myocardial infarction.  
  • Every $1 spent on technological innovations in heart attack care has produced an estimated $7 gain.